Cargando…

Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report

BACKGROUND: Treatment-resistance is recognized as a significant dilemma in schizophrenia, which has been reported to involve approximately one-third of patients with schizophrenia. CASE PRESENTATION: This case report described a 12-week treatment course for a 39-year-old Persian man with treatment-r...

Descripción completa

Detalles Bibliográficos
Autor principal: Khosravi, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460790/
https://www.ncbi.nlm.nih.gov/pubmed/32867840
http://dx.doi.org/10.1186/s13256-020-02484-9